history, page-2

Apart from gold at the moment it is such a bear market that even Billy Graham could not talk up Cellestis and you know the charisma and backing he had.

However it is a great buying opportunity for those with some cash.

Around the world guidelines/protocols have to change first and this can be a slow process because you are dealing with medical bureaucrats and bean counters. The bean counters initially only see the comparitive costs of TST and QFT. Cellestis needs to put together some very substanitial indisputable economic cost benefit studies. So far I feel they have argued the economic benefits on some good but limited data. This can not be put together in a short time frame - you need large numbers. Meanwhile the underswell of support with the opinion leaders at the clinical coal face will be still gathering momentum.